Polivy 140 mg and 30 mg powder for concentrate for solution for infusion

Company:
Roche Registration GmbH
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Polatuzumab Vedotin
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/19/1388/001

140 milligram(s)

L01FX14,L01F

Powder for concentrate for Solution for infusion

EU/1/19/1388/002

30 milligram(s)

L01FX14,L01F

Powder for concentrate for Solution for infusion